G

Structure Therapeutics
D

GPCR

79.840
USD
10.50
(15.14%)
مفتوح الان
حجم التداول
118,305
الربح لكل سهم
-4
العائد الربحي
-
P/E
-22
حجم السوق
5,639,831,972
المقالات

العنوان: Structure Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leveragesboth structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable andoperating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.